Gastrointestinal discomfort is the main reason people stop using allulose
As I was writing this article (Feb 27, ~5:45 AM EST), I reached out to him for clarification either to provide an updated or corrected comment, or to point me toward data I may be overlooking (which is entirely possible)
Tirzepatide and Retatrutide, dual- and triple-action incretin agonists respectively, precisely modulate appetite, insulin sensitivity, and lipid metabolism, while SLU-PP-332, an emerging metabolic modulator, enhances fat oxidation and cellular endurance
As always, I welcome your thoughts and would love to hear your experiences in the comments
CJC-1295 amplifies these natural pulses rather than creating a constant, supraphysiological GH level
Working With a Trainer While on GLP-1 Medication An increasing number of physicians in the Charleston area are now referring patients starting GLP-1 medications directly to strength coaches, recognizing that medication alone without a resistance training plan leaves too much muscle mass on the table